Ironwood Pharmaceuticals Provides First Quarter 2018 Investor Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. MRVL
2. USO
3. SPY
4. BBIO
5. NVDA
6. GOOGL
7. OPCH
8. CHRW
9. AMD
10. STZ

Go back to Ironwood Pharmaceuticals Provides First Quarter 2018 Investor Update

Ironwood Pharma (IRWD) to Resume Trading at 8:30 am ET

May 1, 2018 8:20 AM EDT

Ironwood Pharma (NASDAQ: IRWD) to Resume Trading at 8:30 am ET

... More

Ironwood Pharma (IRWD) to Separate Soluble Guanylate Cyclase Business from Commercial and Gastrointestinal Business

May 1, 2018 8:00 AM EDT

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotech company, today announced that its Board of Directors has authorized an intent to separate into two independent, publicly traded companies (Ironwood and R&D Co.). The separation is expected to be completed in the first half of 2019 and is anticipated to be tax-free to Ironwood shareholders.

... More

Ironwood Pharma (IRWD) Misses Q1 EPS by 4c

May 1, 2018 7:56 AM EDT

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.27), $0.04 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $69.16 million versus the consensus estimate of $78.87 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

... More